Mycophenolate mofetil 250 MG Oral Capsule — RxCUI 199058
RxNorm drug concept · Semantic clinical drug
RxCUI 199058
Semantic clinical drug · SCD
● Current RxNorm concept 31 FDA products
61 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI199058
Official nameMycophenolate mofetil 250 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped31
Package NDCs mapped61
Reported Medicaid activity (SDUD)265,084 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Mycophenolate Mofetil: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It helps keep your body from rejecting a transplanted kidney, heart or liver. You take it together with other immunosuppressant medicines. It works by calming the immune cells that...
- It's usually taken twice a day, by mouth as a capsule, tablet or liquid, or through an IV in the hospital. Follow your prescriber's directions and your label. Don't switch it with...
- Diarrhea, nausea, vomiting and stomach pain are common. Call your doctor if you have a fever, chills or other signs of infection, unusual bruising or bleeding, black stools, severe...
- What side effects are normal, and when should I call?
🕸️ Concept Web — How Mycophenolate mofetil 250 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Mycophenolate mofetil 250 MG Oral Capsule
RxCUI 199058 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Mycophenolate mofetil
68149IN
-
Mycophenolate mofetil
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Cellcept
152633BN
-
Cellcept
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Mycophenolate mofetil Oral Capsule
379060SCDF -
Mycophenolate mofetil Oral Product
1157871SCDG -
Mycophenolate mofetil Pill
1157872SCDG -
Mycophenolate mofetil Oral Capsule [Cellcept]
616446SBDF -
Cellcept Oral Product
1166215SBDG -
Cellcept Pill
1166216SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Mycophenolate mofetil Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Mycophenolate mofetil 250 MG
316316SCDC -
Mycophenolate mofetil 250 MG Oral Capsule [Cellcept]
616447SBD -
Mycophenolate mofetil 250 MG [Cellcept]
616445SBDC
-
Mycophenolate mofetil 250 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Mycophenolate mofetil 250 MG
SCDC · 316316 -
Mycophenolate mofetil Oral Capsule
SCDF · 379060 -
Mycophenolate mofetil Oral Product
SCDG · 1157871 -
Mycophenolate mofetil Pill
SCDG · 1157872
Brand-Name Concepts
-
Mycophenolate mofetil 250 MG Oral Capsule [Cellcept]
SBD · 616447 -
Mycophenolate mofetil 250 MG [Cellcept]
SBDC · 616445 -
Mycophenolate mofetil Oral Capsule [Cellcept]
SBDF · 616446 -
Cellcept Oral Product
SBDG · 1166215 -
Cellcept Pill
SBDG · 1166216 -
Cellcept
BN · 152633
📦 FDA Products & Package NDCs
31 products · 61 package NDCs
61 package NDCs map to RxCUI 199058 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00004-0259-01 | 1 BOTTLE, PLASTIC in 1 CARTON (0004-0259-01) / 100 CAPSULE... | CellCept | Genentech, Inc. | 1995-05-03 |
| 00004-0259-43 | 1 BOTTLE, PLASTIC in 1 CARTON (0004-0259-43) / 500 CAPSULE... | CellCept | Genentech, Inc. | 1995-05-03 |
| 00004-0260-01 | 1 BOTTLE, PLASTIC in 1 CARTON (0004-0260-01) / 100 TABLET,... | CellCept | Genentech, Inc. | 1997-06-19 |
| 00004-0260-43 | 1 BOTTLE, PLASTIC in 1 CARTON (0004-0260-43) / 500 TABLET,... | CellCept | Genentech, Inc. | 1997-06-19 |
| 00004-0261-29 | 1 BOTTLE, PLASTIC in 1 CARTON (0004-0261-29) / 225 mL in 1... | CellCept | Genentech, Inc. | 1998-10-01 |
| 00004-0298-09 | 4 VIAL in 1 CARTON (0004-0298-09) / 20 mL in 1 VIAL | CellCept | Genentech, Inc. | 1998-08-12 |
| 00054-0166-25 | 100 TABLET in 1 BOTTLE (0054-0166-25) | Mycophenolate Mofetil | Hikma Pharmaceuticals USA Inc. | 2008-07-29 |
| 00054-0166-29 | 500 TABLET in 1 BOTTLE (0054-0166-29) | Mycophenolate Mofetil | Hikma Pharmaceuticals USA Inc. | 2008-07-29 |
| 00093-7334-01 | 100 CAPSULE in 1 BOTTLE (0093-7334-01) | Mycophenolate Mofetil | Teva Pharmaceuticals USA, Inc. | 2009-05-06 |
| 00093-7334-05 | 500 CAPSULE in 1 BOTTLE (0093-7334-05) | Mycophenolate Mofetil | Teva Pharmaceuticals USA, Inc. | 2009-05-06 |
| 00781-2067-01 | 100 CAPSULE in 1 BOTTLE (0781-2067-01) | Mycophenolate Mofetil | Sandoz Inc | 2008-10-15 |
| 00781-2067-05 | 500 CAPSULE in 1 BOTTLE (0781-2067-05) | Mycophenolate Mofetil | Sandoz Inc | 2008-10-15 |
| 00781-2067-72 | 120 CAPSULE in 1 BOTTLE (0781-2067-72) | Mycophenolate Mofetil | Sandoz Inc | 2008-10-15 |
| 00781-2067-89 | 12 CAPSULE in 1 CARTON (0781-2067-89) | Mycophenolate Mofetil | Sandoz Inc | 2008-10-15 |
| 00781-5175-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0781-5175-01) | Mycophenolate Mofetil | Sandoz Inc | 2008-10-15 |
| 00781-5175-05 | 500 TABLET, FILM COATED in 1 BOTTLE (0781-5175-05) | Mycophenolate Mofetil | Sandoz Inc | 2008-10-15 |
| 00781-5175-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (0781-5175-10) | Mycophenolate Mofetil | Sandoz Inc | 2008-10-15 |
| 00904-7466-61 | 100 BLISTER PACK in 1 CARTON (0904-7466-61) / 1 CAPSULE in... | mycophenolate mofetil | Major Pharmaceuticals | 2025-12-11 |
| 16729-0019-01 | 100 TABLET in 1 BOTTLE (16729-019-01) | mycophenolate mofetil | Accord Healthcare Inc. | 2009-05-04 |
| 16729-0019-16 | 500 TABLET in 1 BOTTLE (16729-019-16) | mycophenolate mofetil | Accord Healthcare Inc. | 2009-05-04 |
| 16729-0094-01 | 100 CAPSULE in 1 BOTTLE (16729-094-01) | mycophenolate mofetil | Accord Healthcare Inc. | 2009-05-04 |
| 16729-0094-16 | 500 CAPSULE in 1 BOTTLE (16729-094-16) | mycophenolate mofetil | Accord Healthcare Inc. | 2009-05-04 |
| 23155-0830-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (23155-830-01) | Mycophenolate mofetil | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2022-06-30 |
| 23155-0830-05 | 500 CAPSULE in 1 BOTTLE, PLASTIC (23155-830-05) | Mycophenolate mofetil | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2022-06-30 |
| 23155-0836-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (23155-836-01) | Mycophenolate mofetil | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2022-10-15 |
| 23155-0836-05 | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (23155-836-05) | Mycophenolate mofetil | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2022-10-15 |
| 31722-0878-01 | 1 BOTTLE in 1 CARTON (31722-878-01) / 100 CAPSULE in 1 BOTT... | Mycophenolate Mofetil | Camber Pharmaceuticals, Inc. | 2024-10-22 |
| 31722-0878-05 | 500 CAPSULE in 1 BOTTLE (31722-878-05) | Mycophenolate Mofetil | Camber Pharmaceuticals, Inc. | 2024-12-12 |
| 50268-0557-15 | 50 BLISTER PACK in 1 BOX (50268-557-15) / 1 CAPSULE in 1 BL... | mycophenolate mofetil | AvPAK | 2023-05-15 |
| 50268-0558-15 | 50 BLISTER PACK in 1 BOX (50268-558-15) / 1 TABLET, FILM CO... | Mycophenolate Mofetil | AvPAK | 2023-05-15 |
| 59651-0624-01 | 100 CAPSULE in 1 BOTTLE (59651-624-01) | Mycophenolate mofetil | Aurobindo Pharma Limited | 2024-01-05 |
| 59651-0624-05 | 500 CAPSULE in 1 BOTTLE (59651-624-05) | Mycophenolate mofetil | Aurobindo Pharma Limited | 2024-01-05 |
| 60687-0885-01 | 100 BLISTER PACK in 1 CARTON (60687-885-01) / 1 CAPSULE in... | mycophenolate mofetil | American Health Packaging | 2025-03-02 |
| 64380-0725-06 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64380-725-06) | Mycophenolate mofetil | Strides Pharma Science Limited | 2010-11-06 |
| 64380-0725-07 | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64380-725-07) | Mycophenolate mofetil | Strides Pharma Science Limited | 2010-11-06 |
| 64380-0726-06 | 100 CAPSULE in 1 BOTTLE, PLASTIC (64380-726-06) | Mycophenolate mofetil | Strides Pharma Science Limited | 2010-11-06 |
| 64380-0726-07 | 500 CAPSULE in 1 BOTTLE, PLASTIC (64380-726-07) | Mycophenolate mofetil | Strides Pharma Science Limited | 2010-11-06 |
| 65050-2073-00 | 100 CAPSULE in 1 BOTTLE, PLASTIC (65050-2073-0) | Mycophenolate Mofetil | Wuxi Fortune Pharmaceutical Co.,Ltd. | 2025-11-10 |
| 67877-0225-01 | 100 TABLET, FILM COATED in 1 BOTTLE (67877-225-01) | Mycophenolate Mofetil | Ascend Laboratories, LLC | 2011-11-28 |
| 67877-0225-05 | 500 TABLET, FILM COATED in 1 BOTTLE (67877-225-05) | Mycophenolate Mofetil | Ascend Laboratories, LLC | 2011-11-28 |
| 67877-0225-38 | 10 BLISTER PACK in 1 CARTON (67877-225-38) / 10 TABLET, FIL... | Mycophenolate Mofetil | Ascend Laboratories, LLC | 2011-11-28 |
| 67877-0225-84 | 3 BLISTER PACK in 1 CARTON (67877-225-84) / 10 TABLET, FILM... | Mycophenolate Mofetil | Ascend Laboratories, LLC | 2011-11-28 |
| 67877-0266-01 | 100 CAPSULE in 1 BOTTLE (67877-266-01) | mycophenolate mofetil | Ascend Laboratories, LLC | 2010-01-01 |
| 67877-0266-05 | 500 CAPSULE in 1 BOTTLE (67877-266-05) | mycophenolate mofetil | Ascend Laboratories, LLC | 2010-01-01 |
| 67877-0266-38 | 10 BLISTER PACK in 1 CARTON (67877-266-38) / 10 CAPSULE in... | mycophenolate mofetil | Ascend Laboratories, LLC | 2010-01-01 |
| 67877-0266-84 | 3 BLISTER PACK in 1 CARTON (67877-266-84) / 10 CAPSULE in 1... | mycophenolate mofetil | Ascend Laboratories, LLC | 2010-01-01 |
| 68254-5000-01 | 100 CAPSULE in 1 BOTTLE (68254-5000-1) | MYCOPHENOLATE MOFETIL | CONCORD BIOTECH LIMITED | 2019-10-01 |
| 68254-5000-02 | 500 CAPSULE in 1 BOTTLE (68254-5000-2) | MYCOPHENOLATE MOFETIL | CONCORD BIOTECH LIMITED | 2019-10-01 |
| 68254-5003-01 | 30 TABLET in 1 BOTTLE (68254-5003-1) | MYCOPHENOLATE MOFETIL | CONCORD BIOTECH LIMITED | 2020-12-21 |
| 68254-5003-02 | 100 TABLET in 1 BOTTLE (68254-5003-2) | MYCOPHENOLATE MOFETIL | CONCORD BIOTECH LIMITED | 2020-12-21 |
Observed labelers:
Ascend Laboratories, LLC (8) ·
Sandoz Inc (7) ·
Genentech, Inc. (6) ·
CONCORD BIOTECH LIMITED (5) ·
Accord Healthcare Inc. (4) ·
Advagen Pharma Limited (4)
· +12 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J7517 | Mycophenolate mofetil oral | 32 | CMS |
| J7519 | Inj. mycophenolate mofetil | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.